Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 4Unknown 2Terminated 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Glioma 1Cognitive Dysfunction 1Cognition Disorders 1Chemotherapy-Related Cognitive Impairment 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER × Cognitive Training × Clear all
NCT06103318 2024-03-06

ICOgnition

Institut Català d'Oncologia

Phase NA Unknown
176 enrolled
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Cognitive Dysfunction

NCT00256425 2008-03-21

Cognitive Rehabilitation of Glioma Patients

UMC Utrecht

Phase 3 Unknown
140 enrolled
CNS

Brain Neoplasms, Cognition Disorders, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡